Skip to main content
. 2022 Jun 24;2:73. doi: 10.1038/s43856-022-00137-0

Fig. 5. Kaplan–Meier survival analysis including all patients in the study.

Fig. 5

a Male patients. b female patients. Failure defined as revision secondary to ALVAL (moderate or severe). The patients have been sub-divided according to implant type (hip resurfacing or THR) and genotype (possession of HLA-DQA1*02:01-DQB1*02:02). Failure rates at 12 years are shown at the bottom right of the charts (with 95% confidence intervals).